日间病房模式对炎症性肠病患者使用生物制剂的影响

Effects of daytime care ward mode on the use of biological agents in patients with inflammatory bowel disease

目的:探讨日间病房模式对炎症性肠病(IBO)患者行生物制剂治疗的影响。方法:建立生物制剂日间病房,根据建立日间病房的时间,分为对照组(2020年1~10月采用常规住院模式患者23例)和观察组(2021年3~10月采用日间病房住院模式患者33例),比较两组患者的住院时间、焦虑状态及满意度。结果:两组患者出院时焦虑评分均较入院时下降(P<0.05),且观察组患者焦虑评分下降幅度大于对照组(P<0.05)。观察组患者住院时间短于对照组(P<0.05)。观察组患者的满意程度优于对照组(P<0.05)。结论:生物制剂日间病房的使用缩短了患者的住院时间,减轻了患者的焦虑程度,患者满意度得以提升,可满足患者医疗需求,提升就医感受,减轻患者负担,提升医疗服务质量及服务品质。

Objective:To observe the effects of daytime care ward mode on the treatment of patients with inflammatory bowel disease.Methods:A day care ward was initially established for patients undergoing therapy with biological agents.Then the patients were divided into control group(treated on hospital stay basis between January and October of 2020)and observational group(treated on daytime ward basis between March and October of 2021).The two groups were compared regarding the days of hospital stay,state of anxiety state and satisfaction of patients.Results:The scoring on anxiety was decreased at discharge in the two groups of patients compared with that at admission(P<0.05),and the decrease in anxiety scores was greater in observational group than in control group(P<0.05).Patients in the observational group had shorter days of hospital stay,yet higher satisfaction with the treatment than those in the control group(both P<0.05).Conclusion:The daytime care ward mode can reduce the hospital stay and anxiety as well as improve the satisfaction of patients undergoing biological agent administration.In addition,this model can satisfy the medical needs and experience of medical treatment,reduce the burden of patients,and boost the quality of medical services.